SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 19, 2004
CERUS CORPORATION
(Exact name of registrant as specified in its charter)
|
Delaware |
|
0-21937 |
|
68-0262011 |
|
(State of jurisdiction) |
|
(Commission File No.) |
|
(IRS Employer Identification No.) |
|
|
|
|
|
|
|
2411 Stanwell Drive |
||||
|
(Address of principal executive offices and zip code) |
||||
|
|
|
|
|
|
|
Registrant’s telephone number, including area code: (925) 288-6000 |
||||
Item 5. Other Events and Required FD Disclosure.
On May 19, 2004, Cerus Corporation (the “Company”) issued a press release reporting on its Phase III results for the Intercept Plasma System. A copy of the Company’s press release is attached as Exhibit 99.1 hereto and is incorporated herein by reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
|
Exhibit |
|
Description of Exhibit |
|
99.1 |
|
Press Release, dated May 19, 2004, entitled “Cerus Reports Phase III Results for the Intercept Plasma System.” |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
CERUS CORPORATION |
||
|
|
|
|
|
|
|
|
|
|
|
Dated: May 19, 2004 |
By: |
/s/ Gregory W. Schafer |
|
|
|
|
Gregory W. Schafer |
|
|
|
|
Vice President, Finance and |
|
|
|
|
Chief Financial Officer |
|
3
Index to Exhibits
|
Exhibit |
|
Description of Exhibit |
|
99.1 |
|
Press Release, dated May 19, 2004, entitled “Cerus Reports Phase III Results for the Intercept Plasma System.” |
4